Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Chinese Yuan: Range trade holds with modest downside against US Dollar – UOB

Chinese Yuan: Range trade holds with modest downside against US Dollar – UOB

FXStreetFXStreet2026/07/07 22:51
By:FXStreet

UOB’s Quek Ser Leang notes that the US Dollar against the Chinese Yuan has stayed within the previously flagged range, with only modest upward momentum despite a push toward 6.8000. He still sees USD/CNH confined between 6.7750 and 6.8080 over the next 1–3 weeks, with nearby support at 6.7900 and 6.7850 and major resistance at 6.8080.

Dollar stays capped in defined range

"24-HOUR VIEW: Yesterday, we were of the view that USD “is likely to trade in a range between 6.7800 and 6.7930.” We were incorrect, as USD rose to a high of 6.7998. Despite the advance, upward momentum has not increased much. However, USD could potentially rise above 6.8000. The major resistance at 6.8080 is unlikely to come under threat. Support is at 6.7900, followed by 6.7850."

"1-3 WEEKS VIEW: Last Wednesday (01 Jul, spot at 6.7920), we highlighted that the recent USD “strength has come to an end.” We also highlighted that USD “is likely to trade in a range between 6.7750 and 6.8080.” Yesterday (06 Jul, spot at 6.7855), we reiterated our view. We indicated the following: “Although USD has been edging lower since then, there has been no clear increase in downward momentum. In other words, there is no change in our view.”"

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"

After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.

智通财经2026/09/21 09:31
Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"

STONK hits new highs after erasing 27% crash

Cryptopolitan2026/09/21 09:30
STONK hits new highs after erasing 27% crash

25 Days, Four Launches in Sight! Rocket Lab (RKLB.US) Accelerates Rocket Launches to Advance Its Ambitious "Space AI Infrastructure" Goals

After another successful mission, Rocket Lab's 97th Electron rocket is now positioned at the launch pad. This flight will be Rocket Lab's fourth launch in 25 days and its 18th launch in 2026.

智通财经2026/09/21 08:41